Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients

PURPOSE: The presence of metabolic syndrome (MetS) is linked to an increased risk of cardiovascular disease (CVD) development. In this study, CVD risk was calculated among individuals with newly diagnosed MetS using the Framingham Risk Score (FRS) and Globorisk Score. The FRS and Globorisk score are...

Descripción completa

Detalles Bibliográficos
Autores principales: Adil, Syed Omair, Uddin, Fareed, Musa, Kamarul Imran, Khan, Asima, Shakeel, Areebah, Shafique, Kashif, Islam, Md Asiful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518264/
https://www.ncbi.nlm.nih.gov/pubmed/37753441
http://dx.doi.org/10.2147/IJGM.S423151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518264/
https://www.ncbi.nlm.nih.gov/pubmed/37753441
http://dx.doi.org/10.2147/IJGM.S423151

Ejemplares similares